N,5-Dimethyl-N-(4-nitrophenyl)furo[2,3-d]pyrimidin-4-amine

ID: ALA4243157

Chembl Id: CHEMBL4243157

PubChem CID: 145983778

Max Phase: Preclinical

Molecular Formula: C14H12N4O3

Molecular Weight: 284.28

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  Cc1coc2ncnc(N(C)c3ccc([N+](=O)[O-])cc3)c12

Standard InChI:  InChI=1S/C14H12N4O3/c1-9-7-21-14-12(9)13(15-8-16-14)17(2)10-3-5-11(6-4-10)18(19)20/h3-8H,1-2H3

Standard InChI Key:  XPRKNURWZLOLSR-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA4243157

    ---

Associated Targets(Human)

A-431 (6446 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PDGFRB Tclin Platelet-derived growth factor receptor beta (5195 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
KDR Tclin Vascular endothelial growth factor receptor 2 (20924 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
EGFR Tclin Epidermal growth factor receptor erbB1 (33727 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

A10 (235 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Chorioallantoic membrane (375 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 284.28Molecular Weight (Monoisotopic): 284.0909AlogP: 3.21#Rotatable Bonds: 3
Polar Surface Area: 85.30Molecular Species: NEUTRALHBA: 6HBD:
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 1.35CX LogP: 3.29CX LogD: 3.29
Aromatic Rings: 3Heavy Atoms: 21QED Weighted: 0.54Np Likeness Score: -1.04

References

1. Devambatla RKV, Choudhary S, Ihnat M, Hamel E, Mooberry SL, Gangjee A..  (2018)  Design, synthesis and preclinical evaluation of 5-methyl-N4-aryl-furo[2,3-d]pyrimidines as single agents with combination chemotherapy potential.,  28  (18): [PMID:30098869] [10.1016/j.bmcl.2018.07.039]

Source